ADL Bionatur Solutions could incorporate new investors, analyzes to list on other alternative markets
ADL Bionatur Solutions podría dar entrada a nuevos inversores y analizaría cotizar en otros mercados alternativos
Intel ID : 277077
|
||||
| Intel ID | 277077 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - ADL Bionatur Solutions
(31 Dec 2022) |
Revenue: EUR 3,37m EBITDA: EUR 0,42m Net Debt: EUR 152,58m People: 34 |
|
| Date |
 |
|
| Country |  |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.